Loading…
Neuronetics, Inc. is projected to rise to $2.83 by 2027, a +61% move from its current price of $1.76. STIM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.67 | $1.76 | $1.85 | 0.00% |
| Jul 14 | $1.64 | $1.76 | $1.89 | -0.01% |
| Jul 15 | $1.62 | $1.76 | $1.92 | -0.01% |
| Jul 16 | $1.59 | $1.76 | $1.94 | -0.01% |
| Jul 17 | $1.58 | $1.76 | $1.97 | -0.02% |
| Jul 18 | $1.56 | $1.76 | $1.99 | -0.02% |
| Jul 19 | $1.54 | $1.76 | $2.01 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.54 | $1.76 | $2.01 | -0.02% |
| Week 2 | $1.46 | $1.76 | $2.12 | -0.04% |
| Week 3 | $1.40 | $1.76 | $2.21 | -0.06% |
| Week 4 | $1.35 | $1.76 | $2.28 | -0.08% |
| Week 5 | $1.31 | $1.76 | $2.36 | -0.11% |
| Week 6 | $1.28 | $1.76 | $2.42 | -0.13% |
| Week 7 | $1.24 | $1.76 | $2.49 | -0.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc.
has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics, Inc. trades under the STIM symbol in the Healthcare sector. The current price is $1.76, and the company has a market cap of $122.47M and a rank of 4083.
A major floor 42.4% below — a decisive break under it would weaken the trend.
The nearest floor, 31.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 23.3% above — clearing it would confirm fresh momentum.
Key STIM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STIM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.61 | Buy | $1.62 | Buy |
| MA 10 | $1.48 | Buy | $1.52 | Buy |
| MA 20 | $1.37 | Buy | $1.44 | Buy |
| MA 50 | $1.44 | Buy | $1.42 | Buy |
| MA 100 | $1.43 | Buy | $1.52 | Buy |
| MA 200 | $1.74 | Buy | $1.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.65 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 204.79 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 44.26 | Buy |
| Bollinger %B (20,2) | 1.12 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 0.25 | Buy |
| Ultimate (7,14,28) | 87.31 | Sell |
| Momentum (10) | 0.49 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 1.71 | Buy |
| ADX (14) | 16.84 | Neutral |
| ATR (14) | 0.06 | Info |
The current technical picture shows a bullish tilt with RSI(14) at 70, supporting upside momentum. The stock’s moving averages are SMA50 at $1.44 and SMA200 at $1.74, with resistance placed at $1.76 and a support level at $1.20.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.18 | $1.76 | $2.41 | 0% | Neutral | |
| $2.08 | $2.83 | $4.15 | +61% | Bullish | |
| $2.58 | $3.70 | $5.76 | +110% | Bullish | |
| $3.01 | $4.53 | $7.38 | +157% | Bullish | |
| $3.64 | $5.72 | $9.69 | +225% | Bullish | |
| $3.18 | $5.20 | $9.09 | +195% | Bullish | |
| $3.30 | $5.60 | $10.09 | +218% | Bullish | |
| $4.26 | $7.49 | $13.86 | +326% | Bullish | |
| $5.14 | $9.36 | $17.74 | +432% | Bullish | |
| $6.38 | $12.02 | $23.28 | +583% | Bullish | |
| $7.45 | $16.55 | $35.07 | +840% | Bullish | |
| $17.69 | $39.32 | $90.44 | +21.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.18 | $1.76 | $2.06 | +0.00% |
| August 2026 | $1.35 | $1.63 | $2.05 | -7.27% |
| September 2026 | $1.44 | $1.76 | $2.25 | +7.54% |
| October 2026 | $1.49 | $1.84 | $2.39 | +4.81% |
| November 2026 | $1.42 | $1.77 | $2.34 | -3.56% |
| December 2026 | $1.43 | $1.81 | $2.41 | +1.79% |
Click any year to see its month-by-month STIM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, STIM could reach as high as $2.41, with a base case around $1.76 and support toward $1.18 — roughly 0% from $1.76. Price action looks broadly range-bound.
Expect STIM to range from $2.08 to $4.15 through 2027. The $2.83 average target implies a +61% move from current prices. That is up +61% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The STIM price prediction for 2028 points to an average of $3.70 (low $2.58, high $5.76) — a potential gain of +110% on today's $1.76. Momentum favours further upside here.
In 2029, STIM is projected to trade between $3.01 and $7.38, averaging $4.53 — a potential gain of +157% from today's $1.76. That is up +22% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Neuronetics, Inc.'s 2030 outlook centres on $5.72, within a $3.64 to $9.69 range. That is up +26% on the projected 2029 average. That marks a +225% change versus current levels. Momentum favours further upside here.
By 2031, STIM could reach as high as $9.09, with a base case around $5.20 and support toward $3.18 — roughly +195% from $1.76. Buyers look set to stay in control over this stretch.
Expect STIM to range from $3.30 to $10.09 through 2032. The $5.60 average target implies a +218% move from current prices. That is up +8% on the projected 2031 average. Momentum favours further upside here.
The STIM price prediction for 2033 points to an average of $7.49 (low $4.26, high $13.86) — a potential gain of +326% on today's $1.76. Buyers look set to stay in control over this stretch.
In 2034, STIM is projected to trade between $5.14 and $17.74, averaging $9.36 — a potential gain of +432% from today's $1.76. That is up +25% on the projected 2033 average. Momentum favours further upside here.
Neuronetics, Inc.'s 2035 outlook centres on $12.02, within a $6.38 to $23.28 range. That is up +28% on the projected 2034 average. That marks a +583% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, STIM could reach as high as $35.07, with a base case around $16.55 and support toward $7.45 — roughly +840% from $1.76. Momentum favours further upside here.
Expect STIM to range from $17.69 to $90.44 through 2050. The $39.32 average target implies a +21.3x move from current prices. That is up +138% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in STIM today (≈ 568.181818 STIM) could be worth
$22,341.85
+$21,341.85 (+2134%) by 2050 · US Dollar
Based on the average projected STIM price of $39.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STIMwould be worth at today's price.
$1,000 invested in STIM on Jul 10, 2025 (≈ 282.485879 STIM) would be worth
$497.18
-$502.82 (-50.3%) today · 0.50× · US Dollar
Based on a STIM entry price of $3.54 vs. today's $1.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.41 | $1,248.23 | +24.8% |
| 1 month ago | $1.24 | $1,419.35 | +41.9% |
| 3 months ago | $1.35 | $1,303.7 | +30.4% |
| 6 months ago | $1.98 | $888.89 | -11.1% |
| 1 year ago | $3.54 | $497.18 | -50.3% |
| All time (5.0y) ago | $14.51 | $121.3 | -87.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STIM forecast.
Our base-case forecast reaches $3.50 around 2028.
Implied market cap at $3.50: $243.56M
The multi-year forecast outlines a strong upside path. In 2026 the avg is $1.76 with a neutral sentiment. By 2030 the avg rises to $5.72 with a 225% ROI and bullish sentiment. The climb continues to 2040, where the avg is $16.55 and the ROI reaches 840.1% with bullish sentiment, and to 2050, where the avg is $39.32 and the ROI is 2134.2% with bullish sentiment.
The forecast sequence shows ongoing upside through 2031–2050, with higher avg prices and substantial ROIs, though volatility is high (annualized volatility 90%).
Tap a question to reveal the answer.
In 2030 the forecast shows min $3.64, avg $5.72, max $9.69 with ROI 225% and sentiment BULLISH.
Forecasts show a bullish trajectory from 2027 onward, with rising avg prices and positive ROIs (e.g., 2027 avg $2.83, ROI 60.6%; 2030 avg $5.72, ROI 225%), though 2026 is neutral.
The 2050 forecast lists avg $39.32, min $17.69, max $90.44, with ROI 2134.2% and bullish sentiment. While the average is just below 40, the max value exceeds 40.
Current price is $1.76 and market cap is $122.47M.
The 30-day range is $1.27 to $2.44, with annualized volatility of 90%.
Neuronetics, Inc. Community Discussion
0Share your Neuronetics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.